Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

101

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

101 results for “sy”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov24/100

Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Sy

ClinicalTrials.gov study NCT00553943. IPD Sharing: NO. Countries: 2. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Single Ascending Oral Doses of SY-008 in Healthy Subjects

ClinicalTrials.gov study NCT03462589. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Continuous Monitoring of Right Ventricular Function, Based on the Correlation Between the C-X Segment of the Central Venous Pressure Curve, and the Echocardiographic Evaluation of Right Ventricular Sy

ClinicalTrials.gov study NCT03295669. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Multiple Ascending Doses of SY-008 in Type 2 Diabetes Mellitus

ClinicalTrials.gov study NCT04345120. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor

ClinicalTrials.gov study NCT05498519. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Phase II Study of SY-3505 in Patients With ALK-positive NSCLC Who Have Failed Prior Second-Generation ALK TKI

ClinicalTrials.gov study NCT05869162. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Single Ascending Oral Doses of SY-009 in Healthy Subjects

ClinicalTrials.gov study NCT04119947. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors

ClinicalTrials.gov study NCT05291182. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Sy

ClinicalTrials.gov study NCT00801489. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors

ClinicalTrials.gov study NCT06037317. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
geo20/100

AML cell line expression response to SY-1425 (tamibarotene)

GEO Series GSE97331. Homo sapiens. 39 samples. Type: Expression profiling by array.

openGEO-OpenAug 2017View details →
ClinicalTrials.gov20/100

Comparison of the Efficacy of Transcranial Direct Current Stimulation (tDCS) of the Primary Motor Cortex (M1) or the Prefrontal Cortex Combined With Aerobic Activity for Alleviation of Fibromyalgia Sy

ClinicalTrials.gov study NCT06263972. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia

ClinicalTrials.gov study NCT06085638. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Sy

ClinicalTrials.gov study NCT05956600. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
geo16/100

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma [RNA-seq_HS-SY-II]

GEO Series GSE266203. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenAug 2025View details →
geo12/100

SY-1365, a covalent, first in-class CDK7 inhibitor for cancer treatment (ChIP-Seq)

GEO Series GSE121430. Homo sapiens. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenOct 2021View details →
geo12/100

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma [HSH3_ChIP-seq_HS-SY-II]

GEO Series GSE266199. Homo sapiens. 9 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenAug 2025View details →
geo12/100

SY-1365, a covalent, first in-class CDK7 inhibitor for cancer treatment (microarray mRNA)

GEO Series GSE121291. Homo sapiens. 30 samples. Type: Expression profiling by array.

openGEO-OpenOct 2021View details →
geo12/100

SY-1365, a covalent, first in-class CDK7 inhibitor for cancer treatment

GEO Series GSE121431. Homo sapiens. 32 samples. Type: Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by array.

openGEO-OpenOct 2021View details →
zenodo12/100

16S rRNA Gene Sequencing Analysis of the Gut Microbiota of ten Mulberry Silkworms Fed with Mulberry Leaves (SY), ten Artificial Diet (SL), and tem Reverted from Artificial Diet to Mulberry Leaves (ZS)

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Nov 2023View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record